Research letter
Allergenic ingredients in commercial topical cannabinoid preparations

https://doi.org/10.1016/j.jaad.2019.03.015Get rights and content

References (8)

  • L.R.M. Eagleston et al.

    Cannabinoids in dermatology: a scoping review

    Dermatol Online J

    (2018)
  • M. Lim et al.

    Dermatology-related uses of medical cannabis promoted by dispensaries in Canada, Europe, and the United States

    J Cutan Med Surg

    (2018)
  • J.G. DeKoven et al.

    North American Contact Dermatitis Group patch test results: 2015-2016

    Dermatitis

    (2018)
  • A.C. de Groot et al.

    Essential oils, part iv: contact allergy

    Dermatitis

    (2016)
There are more references available in the full text version of this article.

Cited by (8)

  • The impact of cannabis and cannabinoids on the skin

    2023, Cannabis Use, Neurobiology, Psychology, and Treatment
  • Cannabis and the skin

    2021, Clinics in Dermatology
    Citation Excerpt :

    Allergy to additive ingredients in unregulated over-the-counter Cannabis products should be considered as well. A study of California dispensaries found 1 or more allergens from the North American Contact Dermatitis Group were listed in 84% of the products.147 The most common allergens were tocopherol, peppermint/menthol, lavender oil, and fragrance mix.

  • A Survey of Topical Cannabis Use in Canada

    2022, Journal of Cutaneous Medicine and Surgery
View all citing articles on Scopus

Funding sources: None.

Conflicts of interest: None disclosed.

Reprints not available from the authors.

View full text